Czynniki ryzyka powikłań zakrzepowo-zatorowych u pacjentów z migotaniem przedsionków

• Authors: Zubilewicz Renata , Dziurzyńska Magdalena , Jaroszyński Andrzej
• Languages of publication: PL

Keywords

PL

migotanie przedsionków; czynniki ryzyka; powikłania zatorowo-zakrzepowe

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2013
• Issue: 1
• Pages: 46-49

Contributors

author

Zubilewicz Renata

author

Dziurzyńska Magdalena

author

Jaroszyński Andrzej

References

• Camm AJ , Kirchhof P, Lip GY , et al. Guidelines for the management of Atrial Fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC ). Developed with the special contribution of the European
• Heart Rhythm Association (EHRA). Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS ). Eur Heart J 2010; 31: 2369–2429.
• Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NET work (AFNET ) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007; 28: 2803–2817.
• Stewart S, Hart CL , Hole DJ , et al. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359–364.
• Hylek EM, Go AS , Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.N Engl J Med 2003; 349: 1019–1026.
• Gage BF, Waterman AD , Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 22: 2864–2870.
• Van Walraven C, Hart RG, Wells GA , et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003; 8: 936–943.
• Camm AJ , Kirchhof P, Lip GY H, et al. European Society of Cardiology guidelines for the management of atrial fibrillation. Eur Heart J 2010; 31: 2369–2429.
• Lip GY . Implications of the CHA2DS 2-VAS c and HAS -BLED scores for thromboprophylaxis in atrial fibrillation. Am J Med 2011;124: 111–114.
• Lip GY , Frison L, Halperin J, et al. Identifying patients at risk of stroke despite anticoagulation. Stroke 2010 Dec; 41(12):2731–2738.
• Pisters R, Lane DA , Nieuwlaat R, et al. A novel userfriendly score (HAS -BLED ) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey. Chest 2010; 1385: 1093–1100